Ganglioglioma: Clinical Trials

4 trials for Ganglioglioma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Recruiting 1
Phase 11Recruiting 1

Follow Ganglioglioma: new trials by email Literature Review of Ganglioglioma trials Research Report on Ganglioglioma

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
Mirdametinib - Low-Grade Glioma, Recurrent Low-Grade Glioma
Phase 1 / Phase 2RecruitingSt. Jude Children's Research Hospital1322021-06-212026-09-11
Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors
Dabrafenib, trametinib, Carboplatin - Diffuse Astrocytoma, Anaplastic Astrocytoma
Phase 2CompletedNovartis Pharmaceuticals1512017-12-282023-12-13
Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation
Proton radiotherapy - Brain Tumor, Low Grade Glioma
Phase 2CompletedMassachusetts General Hospital1002011-02-012025-06-03
Antineoplaston Therapy in Treating Children With Brain Tumors
Antineoplaston therapy (Atengenal + Astugenal) - Childhood Brain Tumors
Phase 2CompletedBurzynski Research Institute341996-09-012022-03-07

Narrower conditions

Astrocytoma (4)  ·  Neurocytoma (3)  ·  Oligodendroglioma (3)  ·  Ganglioneuroma (2)  ·  Glioblastoma (2)  ·  Brain Neoplasms (1)  ·  Craniopharyngioma (1)  ·  Ependymoma (1)  ·  Glioma (1)  ·  Gliosarcoma (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Neuroectodermal Tumors, Primitive (1)

Broader conditions

Brain Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Central Nervous System Neoplasms (4)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms by Site (4)  ·  Neoplasms, Germ Cell and Embryonal (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Neoplasms, Nerve Tissue (4)  ·  Nervous System Diseases (4)  ·  Nervous System Neoplasms (4)  ·  Neuroectodermal Tumors (4)  ·  Brain Neoplasms (3)  ·  Glioma (3)  ·  Neoplasms, Neuroepithelial (3)

Interventions

Carboplatin (1)  ·  Vincristine (1)  ·  antineoplaston A10 (1)  ·  antineoplaston AS 2-1 (1)  ·  dabrafenib (1)  ·  mirdametinib (1)  ·  trametinib (1)

Sponsors

Burzynski Research Institute (1)  ·  Massachusetts General Hospital (1)  ·  Novartis Pharmaceuticals (1)  ·  St. Jude Children's Research Hospital (1)

Countries

United States (4)  ·  Argentina (1)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)  ·  Netherlands (1)

Top investigators

Anna Vinitsky, MD, MS (1)  ·  Giles W. Robinson, MD (1)  ·  Stanislaw R. Burzynski, MD, PhD (1)  ·  Torunn I. Yock, MD (1)

Results publications

PMID 30118397, PMID 34331515, PMID 37610803, PMID 37643378, PMID 37733309, PMID 41740060

NIH funding

2015 (1)